10-Q/A: CIMG Inc. Q3 Update: Strategic Pivot to Asia, Capital Raises

CIMG Inc. reports a strategic pivot to Asian markets with new health products, significant capital raises, and improved gross profit despite revenue declines, while facing ongoing legal challenges and internal control issues.

Summary

• CIMG Inc. (formerly Nuzee, Inc.) has strategically shifted its focus from specialty coffee to expanding sales and distribution of a broader range of consumer food and beverage products in Asia, leveraging an online sales platform.
• The company introduced the "Maca Series" health-focused product line in Asia during Q4 2024, including Maca Peptide Coffee, Maca-Noni, Maca Purified Powder, and Maca Wine.
• For the three months ended June 30, 2025, revenue decreased by 83.22% to $61,578, primarily due to reduced sales of original single-bag coffee products.
• Gross profit for the three months ended June 30, 2025, improved significantly to $5,133 from a gross loss of $146,213 in the prior-year period, with gross margin at 8.34% (vs. -39.85%).
• Net loss for the three months ended June 30, 2025, improved by 25.83% to $1,068,242 from $1,440,197 in the prior-year period.
• For the nine months ended June 30, 2025, revenue decreased by 94.86% to $84,431, attributed to the strategic shift and new product launch activities.
• Gross profit for the nine months ended June 30, 2025, improved to $20,612 from a gross loss of $178,185 in the prior-year period, with gross margin at 24.41% (vs. -10.85%).
• Net loss for the nine months ended June 30, 2025, improved by 35.89% to $2,990,047 from $5,242,739 in the prior-year period.
• The company completed acquisitions of 51% controlling interests in Beijing Xilin (March 31, 2025) and Shanghai Huomao (April 22, 2025) for no consideration.
• As of June 30, 2025, cash and cash equivalents were $35,958, down from $464,222 as of September 30, 2024.
• Working capital significantly improved to $10,571,104 as of June 30, 2025, from a deficit of $(832,682) as of September 30, 2024.
• The company faces substantial doubt about its ability to continue as a going concern and needs to raise additional capital immediately.
• Management concluded that internal control over financial reporting was not effective as of June 30, 2025.
• Significant capital raises occurred subsequent to the quarter, including $4 million in convertible notes, $55 million worth of bitcoin for shares, and $10 million from warrant exercises.

Sentiment

Score: 4

Explanation: The company shows improved gross profit margins and a reduced net loss, alongside a strategic pivot to new markets and products, and has secured significant capital post-quarter. However, the drastic revenue decline, continued negative operating cash flow, low cash balance at quarter-end, and the "going concern" warning, compounded by ineffective internal controls and ongoing legal issues, present considerable challenges and uncertainty.

Positives

• Significant improvement in gross profit and gross profit margin for both the three and nine months ended June 30, 2025, driven by cost reductions and new product introductions.
• Net loss decreased for both the three-month (25.83% improvement) and nine-month (35.89% improvement) periods ended June 30, 2025.
• Successful execution of a strategic pivot to the Asian market with new health-focused product lines (Maca Series).
• Substantial capital raises totaling $69 million (subsequent to quarter end) significantly improve the company's financial position and address going concern issues.
• Working capital improved from a deficit of $(832,682) to a positive $10,571,104.
• Resolution of the Curtin Litigation with a $125,000 settlement.

Negatives

• Significant decline in revenue for both the three-month (83.22%) and nine-month (94.86%) periods ended June 30, 2025, attributed to the strategic shift and reduced sales of original coffee products.
• Cash and cash equivalents decreased significantly to $35,958 as of June 30, 2025, from $464,222 as of September 30, 2024.
• Net cash used in operating activities worsened to $(11,233,693) for the nine months ended June 30, 2025, from $(4,270,542) in the prior-year period.
• Accumulated deficit increased to $(85,335,700) as of June 30, 2025.
• Management concluded that internal control over financial reporting was not effective as of June 30, 2025.
• Ongoing legal proceedings (Kim Litigation and Ex-Directors Lawsuit) pose financial and operational risks.
• Nasdaq Listing Deficiency for failing to hold an annual meeting, though resolved subsequently.
• Acquisitions of Beijing Xilin and Shanghai Huomao resulted in net liability positions and a loss on acquisition.

Risks

• Ability to obtain funding for operations, including necessary capital to develop, manufacture, and commercialize products, provide co-packing services, and continue as a going concern.
• Need for additional capital to fund planned operations beyond the next three months (as of the original filing date, though subsequent events address this partially).
• Accuracy of estimates regarding expenses, future revenue, capital requirements, and needs for additional financing.
• Ability to maintain compliance with Nasdaq Capital Market listing requirements.
• Impact of changes in general economic, business, and political conditions, including financial markets and macroeconomic conditions.
• Evolving coffee preferences of consumers in North America and East Asia.
• Ability to compete with companies producing similar products or providing similar co-packing services.
• Ability to successfully achieve anticipated results of strategic transactions.
• Reliance on third-party roasters or manufacturing partners.
• Regulatory developments in the U.S. and non-U.S. countries.
• Ability to retain key management, sales, and marketing personnel.
• Scope of protection for intellectual property rights.
• Ability to develop and maintain corporate infrastructure, including internal control over financial reporting.
• Outcome of pending, threatened, or future litigation (Kim Litigation, Ex-Directors Lawsuit).
• Financial performance and use of net proceeds from recent offerings.

Future Outlook

The company is strategically expanding its sales and distribution channels in Asia, focusing on a broader range of consumer food and beverage products, particularly the new Maca Series health-focused line. Management expects these new channel expansions and product launches to support revenue growth in future quarters, specifically the fourth quarter. The company anticipates needing additional capital to fund operations beyond the immediate future, despite recent capital raises.

Management Comments

• "We previously focused on specialty coffee and related technologies but are now expanding our sales and distribution channels in Asia to encompass a broader range of consumer food and beverage products. This expansion is fueled by our online sales platform, which leverages a natural language search function."
• "To strengthen sales performance, management has actively expanded distribution channels and increased product launch activities to establish a stronger foundation for revenue growth in subsequent quarters."
• "The improvement in gross performance was primarily attributable to cost reductions resulting from the introduction of new products and the expansion of new sales channels."
• "The reduction in net loss was primarily attributable to lower product costs, decreased storage expenses, reduced labor compensation, and lower professional service fees during the current period."
• "While we believe our plans to raise additional funds will alleviate the conditions that raise substantial doubt about our ability to continue as a going concern, these plans are not entirely within our control and cannot be assessed as being probable of occurring at this time."
• "If we are unable to raise additional funds when needed, our operations and ability to execute our business strategy could be adversely affected."

Industry Context

The company's pivot to Asia and focus on health-oriented functional beverages like the Maca Series aligns with global trends towards wellness, natural products, and the growing e-commerce market, particularly in rapidly expanding Asian consumer markets. The shift away from traditional single-serve coffee suggests a response to competitive pressures or a re-evaluation of market opportunities in its former core business. The use of AI, neuroscience, and big data for product value reshaping indicates an attempt to leverage advanced technology for competitive advantage in the health and wellness sector.

Corporate Governance

Legal Proceedings

• Curtin Litigation: A former employee's complaint alleging harassment, discrimination, retaliation, and wrongful termination was settled for $125,000 on November 8, 2024, and the case was dismissed on January 22, 2025.
• Kim Litigation: Mr. Sooncha Kim filed a complaint on October 3, 2024, alleging breach of a Convertible Note and Warrant Purchase Agreement, seeking specific performance and $1,041,216 in monetary damages. The company's motion for preliminary injunction was denied, and discovery is ongoing.
• Ex-Directors Lawsuit: Former directors filed a complaint on March 10, 2025, for unpaid directors' fees and expenses. A default judgment was entered on August 22, 2025, for $58,920.34, which was subsequently substantively granted to be amended to a total of $222,062.28 for all four plaintiffs, with an amended judgment form expected imminently.

Related Party Transactions

• As of June 30, 2025, the directors of Wewin Technology LLC paid an administrative fee of $38,500 on behalf of CIMG INC., which the company expects to repay before September 30, 2025.
• SOONCHA KIM lent the Company $320,000 on April 18, 2024, with an outstanding balance of $320,926 at June 30, 2025. (Mr. Kim is also involved in litigation against the company, suggesting a complex related-party dynamic).
• ZHANG XIANG lent the Company $8,696 for nine months ended June 30, 2025, with an outstanding balance of $8,697.

Stakeholder Impact

• Shareholders: Significant dilution from recent and planned capital raises (e.g., 220 million shares for $55 million, 16.6 million shares for $4 million, 25.6 million shares for $10 million). The increase in authorized shares allows for further dilution. The strategic shift to Asia and new product lines could offer long-term growth potential but carries execution risk. Ongoing legal proceedings could result in further financial liabilities.
• Employees: Decreased labor remuneration contributed to reduced operating expenses, potentially impacting employee morale or retention. The strategic shift may lead to changes in staffing needs.
• Customers: The shift from traditional coffee products to the Maca Series in Asia indicates a change in product offerings and target markets. Existing coffee customers may be impacted by reduced product availability.
• Creditors: The company's "going concern" warning and need for immediate capital raise highlight financial instability, though subsequent capital raises improve liquidity. Convertible notes and other loans represent obligations.
• Suppliers: Changes in product lines and manufacturing partners could impact existing supplier relationships.

Next Steps

• Continue expanding distribution channels and increasing product launch activities for the Maca Series in Asia.
• Seek to raise additional capital through equity, equity-linked, or debt financings to fund operations beyond the immediate future.
• Address and improve internal control over financial reporting.
• Monitor and manage ongoing legal proceedings (Kim Litigation, Ex-Directors Lawsuit).
• Resubmit the amended judgment form for the Ex-Directors Lawsuit.
• Evaluate the impact of new accounting pronouncements (ASU 2023-07 and ASU 2023-09) on consolidated financial statements.

Key Dates

Recommendation

The company is undergoing a significant strategic transformation, pivoting to new markets and product lines in Asia, which carries both high potential and high risk. While recent capital raises (post-quarter) have substantially improved liquidity and addressed immediate going concern issues, the quarter's financial results show a drastic revenue decline, continued net losses, and negative operating cash flow. The ineffective internal controls and ongoing legal challenges add to the uncertainty. The stock is highly speculative, but the recent capital injections and strategic focus could provide a foundation for future growth if executed successfully. Investors should hold to observe the execution of the new strategy and the impact of the capital raises on future financial performance, while acknowledging the significant risks involved.

Keywords

CIMG Inc., IMG, SEC Filing, 10-Q/A, Quarterly Report, Financial Results, Maca Series, Health Beverages, Asia Market Expansion, Consumer Food & Beverage, Capital Raise, Private Placement, Convertible Notes, Warrant Exercise, Going Concern, Internal Controls, Legal Proceedings, Nasdaq Listing, China Market, E-commerce, Functional Beverages